Where is Pos-T-Vac located?

Pos-T-Vac is headquartered in Dodge City, United States.

How many employees does Pos-T-Vac have?

As of Jul 01, 2024, the latest employee count at Pos-T-Vac is 12.

Is Pos-T-Vac a funded company?

Pos-T-Vac is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Pos-T-Vac rank among its competitors?

Pos-T-Vac ranks 6th amongst 17 active competitors, of which 3 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Comphya, which secured $9.38M in Jul, 2025.

Who are the top competitors of Pos-T-Vac?

Pos-T-Vac's top competitors include Comphya, Virility Medical and Morari. Among them, Comphya secured the most recent funding round in July, 2025.

Pos-T-Vac - 2026 Company Profile, Team & Competitors

Pos-T-Vac is an unfunded company based in Dodge City (United States), founded in 1987 by Ed Stewart. It operates as a Develops non-surgical treatment of Erectile Dysfunction using Vacuum Therapy. Pos-T-Vac has not raised any funding yet. The company has 17 active competitors, including 3 funded and 1 that has exited. Its top competitors include companies like Comphya, Virility Medical and Morari.

Company Details

Pos-T-Vac develops non-surgical treatment of Erectile Dysfunction using Vacuum Therapy. An erection is achieved by placing the penis in a vacuum cylinder, creating a vacuum which generates blood flow into the penis, which causes engorgement and rigidity.

Website: postvac.com
Social
Email ID: *****@postvac.com
Phone Number: +1 **********

Key Metrics

Founded Year

1987

Location

Dodge City, United States

Stage

Unfunded

Ranked

6^th among 17 active competitors

Employee Count

12 as on Jul 01, 2024

Similar Companies

Comphya & 19 more

View Pos-T-Vac's full profile

Pos-T-Vac has not raised any funding rounds yet.

The founders of Pos-T-Vac is Ed Stewart.

Here are the details of Pos-T-Vac's key team members:

Ed Stewart: Founder & CEO of Pos-T-Vac.
Contact Info: 1 email address

View details of Pos-T-Vac's Founder profiles and Board Members

Pos-T-Vac's employee count trend

Pos-T-Vac has 12 employees as of Jul 24. Here is Pos-T-Vac's employee count trend over the years:

Uncover Pos-T-Vac's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pos-T-Vac include Comphya, Virility Medical and Morari. Here is the list of Top 10 competitors of Pos-T-Vac, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Comphya 2017, Preverenges (Switzerland), Series A	Developer of a neurostimulator implant for treating male impotence	$19.6M	Verve Ventures, FIT & 4 others	54/100
2nd	Virility Medical 2016, Nazareth (Israel), Series A	Provider of a skin patch for the treatment of premature ejaculation	$10M	Arkin Holdings, Migdal Group & 5 others	43/100
3rd	Morari 2018, Maple Grove (United States), Seed	Developer of the device to treat premature ejaculation	-	Gener8tor, gBETA Medtech	39/100
4th	Timm Medical Technologies 1997, Fort Washington (United States), Acquired	Sexual health solutions for men and women, offering devices and support	-	Endocare	33/100
5th	Ohh-Med 2018, Tiberias (Israel), Unfunded	Developer of medical device to treat male erectile dysfunction	-	-	28/100
6th	Pos-T-Vac 1987, Dodge City (United States), Unfunded	Develops non-surgical treatment of Erectile Dysfunction using Vacuum Therapy	-	-	27/100
7th	ZSI 2015, Geneva (Switzerland), Unfunded	Devices for male urological disorders	-	-	27/100
8th	Rigicon 2016, Ronkonkoma (United States), Unfunded	Developer of a inflatable penile and testicular prosthesis to treat erectile dysfunction	-	-	25/100
9th	Bonro Medical 2003, Augusta (United States), Unfunded	ED solutions: Vacuum Erection Devices for effective, non-invasive erectile dysfunction treatment	-	-	25/100
10th	ErectiStim 2016, Los Angeles (United States), Unfunded	Provider of stem cell regeneration treatment for erectile disorder	-	-	24/100